Brief: Puma Biotechnology Announces Publication Of Phase Ii Clinical Trial Of Alisertib In Jama Oncology
14/03/2023 12:43
March 14 (Reuters) - Puma Biotechnology Inc PBYI.O :
* PUMA BIOTECHNOLOGY ANNOUNCES PUBLICATION OF PHASE II
CLINICAL
TRIAL OF ALISERTIB IN JAMA ONCOLOGY
* PUMA BIOTECHNOLOGY ANNOUNCES PUBLICATION OF PHASE II
CLINICAL
TRIAL OF ALISERTIB IN JAMA ONCOLOGY
Source text for Eikon: ID:nBwc80xRRa
Further company coverage: PBYI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Puma Biotechnology
See all newsBrief: Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Corrected: Puma Biotechnology lifts 2026 outlook as Q2 revenue rises on NERLYNX demand
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2